Incremental value of copeptin to highly sensitive cardiac Troponin i for rapid rule-out of myocardial infarction

International Journal of Cardiology

Volumn 190, Issue 1, 2015, Pages 170-176

  Wildi, Karin ^a   Zellweger, Christa ^a   Twerenbold, Raphael ^a   Jaeger, Cedric ^a   Reichlin, Tobias ^a   Haaf, Philip ^a   Faoro, Jonathan ^a   Giménez, Maria Rubini ^a,b,c   Fischer, Andreas ^a   Nelles, Berit ^a   Druey, Sophie ^a   Krivoshei, Lian ^a   Hillinger, Petra ^a   Puelacher, Christian ^a   Herrmann, Thomas ^a   Campodarve, Isabel ^c   Rentsch, Katharina ^a   Steuer, Stephan ^d   Osswald, Stefan ^a   Mueller, Christian ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c Emergency Department   (Spain)

^d Orthopedic Emergency Department   (Switzerland)

Author keywords

Acute myocardial infarction; Copeptin; Highly sensitive Troponin I; Sensitivity and specificity

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COPEPTIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TROPONIN I; BIOLOGICAL MARKER; GLYCOPEPTIDE;

ADULT; AGED; ANAMNESIS; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; BLOOD; CHEST PAIN; CLINICAL TRIAL; INTERNATIONAL COOPERATION; MIDDLE AGED; MULTICENTER STUDY; MYOCARDIAL INFARCTION; PROSPECTIVE STUDY; TIME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS; CHEST PAIN; FEMALE; GLYCOPEPTIDES; HUMANS; INTERNATIONALITY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; TIME FACTORS; TROPONIN I;

EID: 84929191797     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.04.133     Document Type: Article

References (42)

1. C.J. Murray, A.D. Lopez, Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study, Lancet 349 (1997) 1436-1442.
2. A.K. Venkatesh, B.P. Geisler, J.J. Gibson Chambers, C.W. Baugh, J.S. Bohan, J.D. Schuur, Use of observation care in US emergency departments, 2001 to 2008, PLoS One 6 (2011) e24326.
3. J.H. Pope, T.P. Aufderheide, R. Ruthazer, R.H. Woolard, J.A. Feldman, J.R. Beshansky, et al., Missed diagnoses of acute cardiac ischemia in the emergency department, N. Engl. J. Med. 342 (2000) 1163-1170.
4. K. Thygesen, J.S. Alpert, A.S. Jaffe, M.L. Simoons, B.R. Chaitman, H.D. White, et al., Third universal definition of myocardial infarction, Eur. Heart J. 33 (2012) 2551-2567.
5. T. Reichlin, W. Hochholzer, S. Bassetti, S. Steuer, C. Stelzig, S. Hartwiger, et al., Early diagnosis of myocardial infarction with sensitive cardiac troponin assays, N. Engl. J. Med. 361 (2009) 858-867.
6. R. Twerenbold, A. Jaffe, T. Reichlin, M. Reiter, C. Mueller, High-sensitive troponin T measurements: What do we gain and what are the challenges? Eur. Heart J. 33 (2012) 579-586.
7. K. Thygesen, J. Mair, H. Katus,M. Plebani, P. Venge, P. Collinson, et al., Recommendations for the use of cardiac troponin measurement in acute cardiac care, Eur. Heart J. 31 (2010) 2197-2204.
8. Y. Gu, A. Voors, F. Zijlstra, H. Hillege, J. Struck, S. Masson, et al., Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction, Clin. Res. Cardiol. 100 (2011) 1069-1076.
9. T. Reichlin,W. Hochholzer, C. Stelzig, K. Laule, H. Freidank, N.G. Morgenthaler, et al., Incremental value of copeptin for rapid rule out of acute myocardial infarction, J. Am. Coll. Cardiol. 54 (2009) 60-68.
10. A. Maisel, C. Mueller, S.-X. Neath, R.H. Christenson, N.G. Morgenthaler, J. McCord, et al., Copeptin helps in the early detection of patients with acute myocardial infarction: Primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction), J. Am. Coll. Cardiol. 62 (2013) 150-160.
11. T. Keller, S. Tzikas, T. Zeller, E. Czyz, L. Lillpopp, F.M. Ojeda, et al., Copeptin improves early diagnosis of acute myocardial infarction, J. Am. Coll. Cardiol. 55 (2010) 2096-2106.
12. C. Balmelli, C.Meune, R. Twerenbold, T. Reichlin, S. Rieder, B. Drexler, et al., Comparison of the performances of cardiac troponins, including sensitive assays, and copeptin in the diagnostic of acute myocardial infarction and long-term prognosis between women and men, Am. Heart J. 166 (2013) 30-37.
13. C. Mueller, Counterpoint: Detection of myocardial infarction-is it all troponin? Role of new markers, Clin. Chem. 58 (2012) 162-164.
14. U. Lotze, H. Lemm, A. Heyer, K. Muller, Combined determination of highly sensitive troponin T and copeptin for early exclusion of acute myocardial infarction: First experience in an emergency department of a general hospital, Vasc. Health Risk Manag. 7 (2011) 509-515.
15. M. Karakas, J.L. Januzzi, J. Meyer, H. Lee, C.L. Schlett, Q.A. Truong, et al., Copeptin does not add diagnostic information to high-sensitivity troponin T in low-to intermediate-risk patients with acute chest pain: Results from the rule out myocardial infarction by computed tomography (ROMICAT) study, Clin. Chem. 57 (2011) 1137-1145.
16. P. Llorens, M. Sánchez, P. Herrero, F.J. Martín-Sánchez, P. Piñera, O. Miró, The utility of copeptin in the emergency department for non-ST-elevation myocardial infarction rapid rule out: COPED-MIRRO study, Eur. J. Emerg. Med. 21 (2013) 220-229.
17. D. Afzali, M. Erren, H.-J. Pavenstädt, J.O. Vollert, S. Hertel, J. Waltenberger, et al., Impact of copeptin on diagnosis, risk stratification, and intermediate-term prognosis of acute coronary syndromes, Clin. Res. Cardiol. 102 (2013) 755-763.
18. S. Charpentier, B. Lepage, F. Maupas-Schwalm, C. Cinq-Frais, M. Bichard-Bréaud, J.M. Botella, et al., Copeptin improves the diagnostic performance of sensitive troponin IUltra but cannot rapidly rule out non-ST-elevation myocardial infarction at presentation to an emergency department, Ann. Emerg. Med. 61 (2013) 549.e1-549.e58.
19. T. Reichlin, A. Irfan, R. Twerenbold, M. Reiter, W. Hochholzer, H. Burkhalter, et al., Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction, Circulation 124 (2011) 136-145.
20. M. Reiter, R. Twerenbold, T. Reichlin, B. Benz, P. Haaf, J. Meissner, et al., Early diagnosis of acute myocardial infarction in patients with pre-existing coronary artery disease using more sensitive cardiac troponin assays, Eur. Heart J. 33 (2011) 988-997.
21. P. Haaf, B. Drexler, T. Reichlin, R. Twerenbold, M. Reiter, J. Meissner, et al., Highsensitivity cardiac troponin in the distinction of acute myocardial infarction from acute cardiac noncoronary artery disease, Circulation 126 (2012) 31-40.
22. T. Reichlin, C. Schindler, B. Drexler, R. Twerenbold, M. Reiter, C. Zellweger, et al., One-hour rule-out and rule-in of acute myocardial infarction using highsensitivity cardiac troponin T, Arch. Intern. Med. 172 (2012) 1211-1218.
23. K. Thygesen, J.S. Alpert, H.D.White, Joint ESCAAHAWHFTF for the R of MI. Universal definition of myocardial infarction, Eur. Heart J. 28 (2007) 2525-2538.
24. K. Thygesen, J. Mair, E. Giannitsis, C. Mueller, B. Lindahl, S. Blankenberg, et al., How to use high-sensitivity cardiac troponins in acute cardiac care, Eur. Heart J. 33 (2012) 2252-2257.
25. F.S. Apple, A.H.Wu, A.S. Jaffe, M. Panteghini, R.H. Christenson, C.P. Cannon, et al., National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: Analytical issues for biomarkers of heart failure, Circulation 116 (2007) e95-e98.
26. F.S. Apple, Cardiac troponin monitoring for detection of myocardial infarction: Newer generation assays are here to stay, Clin. Chim. Acta 380 (2007) 1-6.
27. F.S. Apple, S.W. Smith, L.A. Pearce, R. Ler, M.M. Murakami, Use of the Centaur TnIUltra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome, Clin. Chem. 54 (2008) 723-728.
28. S.E. Melanson, D.A. Morrow, P. Jarolim, Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity, Am. J. Clin. Pathol. 128 (2007) 282-286.
29. P.A. Kavsak, A.R. MacRae, M.J. Yerna, A.S. Jaffe, Analytic and clinical utility of a nextgeneration, highly sensitive cardiac troponin I assay for early detection of myocardial injury, Clin. Chem. 55 (2009) 573-577.
30. Q. Lam, M. Black, O. Youdell, H. Spilsbury, H.-G. Schneider, Performance evaluation and subsequent clinical experience with the Abbott Automated Architect STAT Troponin-I assay, Clin. Chem. 52 (2006) 298-300.
31. E.R. DeLong, D.M. DeLong, D.L. Clarke-Pearson, Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach, Biometrics 44 (1988) 837-845.
32. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., R.S. Vasan, Evaluating the added predictive ability of a newmarker: Fromarea under the ROC curve to reclassification and beyond, Stat. Med. 27 (2008) 112-157.
33. J. Thelin, C. Borna, D. Erlinge, B. Ohlin, The combination of high sensitivity troponin T and copeptin facilitates early rule-out of ACS: A prospective observational study, BMC Cardiovasc. Disord. 13 (2013) 42.
34. M. Sebbane, S. Lefebvre, N. Kuster, R. Jreige, E. Jacques, S. Badiou, et al., Early rule out of acute myocardial infarction in ED patients: Value of combined high-sensitivity cardiac troponin T and ultrasensitive copeptin assays at admission, Am. J. Emerg. Med. 31 (2013) 1302-1308.
35. E. Giannitsis, T. Kehayova,M. Vafaie, H.A. Katus, Combined testing of high-sensitivity troponin T and copeptin on presentation at prespecified cutoffs improves rapid ruleout of non-ST-segment elevation myocardial infarction, Clin. Chem. 57 (2011) 1452-1455.
36. D. Giavarina, M. Carta, A. Fortunato,M.L. Wratten, O. Hartmann, G. Soffiati, Copeptin and high sensitive troponin for a rapid rule out of acute myocardial infarction? Clin. Lab. 57 (2011) 725-730.
37. R. Hoeller, M. Rubini Giménez, T. Reichlin, R. Twerenbold, C. Zellweger, B.Moehring, et al., Normal presenting levels of high-sensitivity troponin and myocardial infarction, Heart 1-6 (2013).
38. T. Keller, T. Zeller, F. Ojeda, S. Tzikas, L. Lillpopp, C. Sinning, et al., Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction, JAMA 306 (2011) 2684-2693.
39. M. Mueller, M. Biener, M. Vafaie, S. Doerr, T. Keller, S. Blankenberg, et al., Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome, Clin. Chem. 58 (2012) 209-218.
40. S. Jochberger, N.G. Morgenthaler, V.D. Mayr, G. Luckner, V. Wenzel, H. Ulmer, et al., Copeptin and arginine vasopressin concentrations in critically ill patients, J. Clin. Endocrinol. Metab. 91 (2006) 4381-4386.
41. C.W. Hamm, J.-P. Bassand, S. Agewall, J. Bax, E. Boersma, H. Bueno, et al., ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC), Eur. Heart J. 32 (2011) 2999-3054.
42. O. Hammarsten, M.L.X. Fu, R. Sigurjonsdottir, M. Petzold, L. Said, K. Landin-Wilhelmsen, et al., Troponin T percentiles from a random population sample, emergency room patients and patients with myocardial infarction, Clin. Chem. 58 (2012) 628-637.